Replies to post #136671 on Biotech Values

[DewDiligence]

EXAS CFO, Maneesh Arora, gets additional title of COO:

http://finance.yahoo.com/news/Exact-Sciences-Promotes-Arora-bw-3716808086.html?x=0

[DewDiligence]

More EXAS factoids (from JMP webcast)—75% of the $14B US disease burden of colorectal cancer is borne by Medicare. The $14B figure is expected to rise to $17B in the next few years.

[DewDiligence]

EXAS, Mayo Clinic expand R&D collaboration:

http://finance.yahoo.com/news/exact-sciences-extends-expands-relationship-130000061.html

Under an extension of the agreement Exact and Mayo Clinic announced in mid-2009, the company’s research and development collaboration with David A. Ahlquist, M.D., and his lab will be expanded to include all gastrointestinal cancers and diseases, and new cancer screening applications of stool- and blood-based testing. Exact will continue to have exclusive rights to commercialize breakthroughs that result from this collaboration.

Exact will make up-front, milestone and royalty payments to Mayo Clinic. It will continue to fund the collaborative work done in Dr. Ahlquist’s lab.